End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.49 CNY | -0.44% |
|
+2.69% | -10.15% |
12/07 | Fosun Pharma Receives Offers for Share Alternative Offer Related to Henlius Merger Offer | MT |
08/07 | Shanghai Fosun Pharmaceutical (Group) Cancer Treatment Gets NMPA's Nod for Clinical Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.15% | 7.56B | |
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+8.43% | 301B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma Receives Offers for Share Alternative Offer Related to Henlius Merger Offer